37 research outputs found

    Acute Smc5/6 depletion reveals its primary role in rDNA replication by restraining recombination at fork pausing sites

    Full text link
    Smc5/6, a member of the conserved SMC family of complexes, is essential for growth in most organisms. Its exact functions in a mitotic cell cycle are controversial, as chronic Smc5/6 loss-of-function alleles produce varying phenotypes. To circumvent this issue, we acutely depleted Smc5/6 in budding yeast and determined the first cell cycle consequences of Smc5/6 removal. We found a striking primary defect in replication of the ribosomal DNA (rDNA) array. Each rDNA repeat contains a programmed replication fork barrier (RFB) established by the Fob1 protein. Fob1 removal improves rDNA replication in Smc5/6 depleted cells, implicating Smc5/6 in the management of programmed fork pausing. A similar improvement is achieved by removing the DNA helicase Mph1 whose recombinogenic activity can be inhibited by Smc5/6 under DNA damage conditions. DNA 2D gel analyses further show that Smc5/6 loss increases recombination structures at RFB regions; moreover, mph1 Delta and fob1 Delta similarly reduce this accumulation. These findings point to an important mitotic role for Smc5/6 in restraining recombination events when protein barriers in rDNA stall replication forks. As rDNA maintenance influences multiple essential cellular processes, Smc5/6 likely links rDNA stability to overall mitotic growth

    The mutation spectrum in genomic late replication domains shapes mammalian GC content

    Full text link
    Genome sequence compositions and epigenetic organizations are correlated extensively across multiple length scales. Replication dynamics, in particular, is highly correlated with GC content. We combine genome-wide time of replication (ToR) data, topological domains maps and detailed functional epigenetic annotations to study the correlations between replication timing and GC content at multiple scales. We find that the decrease in genomic GC content at large scale late replicating regions can be explained by mutation bias favoring A/T nucleotide, without selection or biased gene conversion. Quantification of the free dNTP pool during the cell cycle is consistent with a mechanism involving replication-coupled mutation spectrum that favors AT nucleotides at late S-phase. We suggest that mammalian GC content composition is shaped by independent forces, globally modulating mutation bias and locally selecting on functional element. Deconvoluting these forces and analyzing them on their native scales is important for proper characterization of complex genomic correlations

    Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer

    Get PDF
    The androgen receptor is a key transcription factor contributing to the development of all stages of prostate cancer (PCa). In addition, other transcription factors have been associated with poor prognosis in PCa, amongst which c-Myc (MYC) is a well-established oncogene in many other cancers. We have previously reported that the AR promotes glycolysis and anabolic metabolism; many of these metabolic pathways are also MYC-regulated in other cancers. In this study, we report that in PCa cells de novo purine biosynthesis and the subsequent conversion to XMP is tightly regulated by MYC and independent of AR activity. We characterized two enzymes, PAICS and IMPDH2, within the pathway as PCa biomarkers in tissue samples and report increased efficacy of established anti-androgens in combination with a clinically approved IMPDH inhibitor, mycophenolic acid (MPA). Treatment with MPA led to a significant reduction in cellular guanosine triphosphate (GTP) levels accompanied by nucleolar stress and p53 stabilization. In conclusion, targeting purine biosynthesis provides an opportunity to perturb PCa metabolism and enhance tumour suppressive stress responses

    Rnr1, but not Rnr3, facilitates the sustained telomerase-dependent elongation of telomeres

    Full text link
    Ribonucleotide reductase (RNR) provides the precursors for the generation of dNTPs, which are required for DNA synthesis and repair. Here, we investigated the function of the major RNR subunits Rnr1 and Rnr3 in telomere elongation in budding yeast. We show that Rnr1 is essential for the sustained elongation of short telomeres by telomerase. In the absence of Rnr1, cells harbor very short, but functional, telomeres, which cannot become elongated by increased telomerase activity or by tethering of telomerase to telomeres. Furthermore, we demonstrate that Rnr1 function is critical to prevent an early onset of replicative senescence and premature survivor formation in telomerase-negative cells but dispensable for telomere elongation by Homology-Directed-Repair. Our results suggest that telomerase has a "basal activity" mode that is sufficient to compensate for the "end-replication-problem" and does not require the presence of Rnr1 and a different "sustained activity" mode necessary for the elongation of short telomeres, which requires an upregulation of dNTP levels and dGTP ratios specifically through Rnr1 function. By analyzing telomere length and dNTP levels in different mutants showing changes in RNR complex composition and activity we provide evidence that the Mec1ATR checkpoint protein promotes telomere elongation by increasing both dNTP levels and dGTP ratios through Rnr1 upregulation in a mechanism that cannot be replaced by its homolog Rnr3

    Hydroxyurea-Mediated Cytotoxicity Without Inhibition of Ribonucleotide Reductase

    Get PDF
    In many organisms, hydroxyurea (HU) inhibits class I ribonucleotide reductase, leading to lowered cellular pools of deoxyribonucleoside triphosphates. The reduced levels for DNA precursors is believed to cause replication fork stalling. Upon treatment of the hyperthermophilic archaeon Sulfolobus solfataricus with HU, we observe dose-dependent cell cycle arrest, accumulation of DNA double-strand breaks, stalled replication forks, and elevated levels of recombination structures. However, Sulfolobus has a HU-insensitive class II ribonucleotide reductase, and we reveal that HU treatment does not significantly impact cellular DNA precursor pools. Profiling of protein and transcript levels reveals modulation of a specific subset of replication initiation and cell division genes. Notably, the selective loss of the regulatory subunit of the primase correlates with cessation of replication initiation and stalling of replication forks. Furthermore, we find evidence for a detoxification response induced by HU treatment

    Chr XII replication is affected in the first cell cycle after Smc5/6 depletion.

    Full text link
    <p>A. Experimental scheme of alpha factor (aF)-induced G1 arrest followed by release into cycling for examination of chromosomal replication. This procedure was used for subsequent figure panels unless otherwise noted. B. FACS profiles of IAA-treated Nse5-Smc6 double degron and control (TIR alone) cells after G1 arrest and synchronized release into first cell cycle progression. C. Western blot showing reduced BrdU incorporation for Chr XII in degron versus control cells in the first cell cycle. Chromosomes were separated by PFGE and new DNA synthesis was detected using an anti-BrdU antibody. D. FACS profiles of G1 arrest and release assays using Nse5-Smc6 double degron treated or not treated with 1 mM IAA. E. Western blot showing reduced Chr XII BrdU incorporation in IAA-treated cells compared with untreated cells in the first cell cycle after G1 release. New DNA synthesis in each chromosome was detected using an anti-BrdU antibody after PFGE. Samples in D and E were run on the same gel, with dotted lines indicating the junction that separates samples from the two strains. The same labeling convention is used for subsequent figures showing PFGE data.</p

    Chr XII replication is affected in the first cell cycle after Smc5/6 depletion.

    Full text link
    <p>A. Experimental scheme of alpha factor (aF)-induced G1 arrest followed by release into cycling for examination of chromosomal replication. This procedure was used for subsequent figure panels unless otherwise noted. B. FACS profiles of IAA-treated Nse5-Smc6 double degron and control (TIR alone) cells after G1 arrest and synchronized release into first cell cycle progression. C. Western blot showing reduced BrdU incorporation for Chr XII in degron versus control cells in the first cell cycle. Chromosomes were separated by PFGE and new DNA synthesis was detected using an anti-BrdU antibody. D. FACS profiles of G1 arrest and release assays using Nse5-Smc6 double degron treated or not treated with 1 mM IAA. E. Western blot showing reduced Chr XII BrdU incorporation in IAA-treated cells compared with untreated cells in the first cell cycle after G1 release. New DNA synthesis in each chromosome was detected using an anti-BrdU antibody after PFGE. Samples in D and E were run on the same gel, with dotted lines indicating the junction that separates samples from the two strains. The same labeling convention is used for subsequent figures showing PFGE data.</p
    corecore